NASDAQ / LIVE COMPANY INTELLIGENCE

Arcadia Biosciences, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERRKDA
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / RKDA COVERAGE

What’s moving Arcadia Biosciences, Inc. now

Current reporting with the operating signal separated from the noise.

01
Arcadia Biosciences, Inc.: Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Arcadia Biosciences, Inc.: Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

The story matters when it changes Arcadia Biosciences, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q1 2025 Earnings Call Transcript

Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q1 2025 Earnings Call Transcript

Investors are testing whether Arcadia Biosciences, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
03
Arcadia Biosciences, Inc. Announces Q1 2025 Financial Results Release and Conference Call Schedule

Arcadia Biosciences, Inc. Announces Q1 2025 Financial Results Release and Conference Call Schedule

The story matters when it changes Arcadia Biosciences, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q2 2024 Earnings Call Transcript

Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q2 2024 Earnings Call Transcript

Investors are testing whether Arcadia Biosciences, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
05
Arcadia Biosciences, Inc. (RKDA) Q1 2023 Earnings Call Transcript

Arcadia Biosciences, Inc. (RKDA) Q1 2023 Earnings Call Transcript

Investors are testing whether Arcadia Biosciences, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
PRIMARY DOCUMENTS / SEC EDGAR

Latest RKDA filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-14 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-07 · Period 2025-09-30SEC ↗10-K/AAnnual financial reportFiled 2026-04-30 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-02 · Period 2026-07-01SEC ↗8-KMaterial company eventFiled 2026-06-15 · Period 2026-06-11SEC ↗8-KMaterial company eventFiled 2026-05-14 · Period 2026-05-14SEC ↗DEF 14AProxy and shareholder meetingFiled 2025-11-19 · Period 2025-12-19SEC ↗PRE 14AOfficial SEC filingFiled 2026-07-31 · Period 2025-12-31SEC ↗
EARNINGS / QUARTERLY TRACKER

Arcadia Biosciences, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.

Q1

First quarter

SEARCH Q1 COVERAGE →